Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, April 25, 2024.
Range Cancer Therapeutics ETF (NASDAQ:CNCR)
Crossroads (-60) - CNCR is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CNCR
The long-term trend has been UP since Dec 14th, 2023 at 12.27
The intermediate-term trend has been DOWN since Mar 18th, 2024 at 15.85
The short-term trend has been DOWN since Apr 3rd, 2024 at 15.77
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 14.26 | 14.26 | 13.77 | 13.95 | -0.28 |
| Prev. Close | Volume | Bid | Ask | Time |
| 14.23 | 6160 | 2024-04-25 15:41:23 |
| Year High | 32.32 | Year High Date | 2018-03-13 |
| Year Low | 19.1252 | Year Low Date | 2018-10-29 |
| 52wk High | 17.9599 | 52wk High Date | 2024-03-01 |
| 52wk Low | 9.22 | 52wk Low Date | 2023-10-27 |
| Average Volume | 10,836 | Shares Outstanding | 100 |
| Market Cap | 34M | Volatility | 39.81 |